Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
www.MarketResearchReports.com
: an industry
analysis of
technologies, pipelines,
stakeholders & deals an
industry analysis...
www.MarketResearchReports.com
Introduction to Report
 Launch Date: May 20, 2018
 Number of Pages: 294
 Geography Covera...
www.MarketResearchReports.com
About the Report
T-Cell Receptors (TCR) and Chimeric Antigen
Receptors (CAR) are the cutting...
www.MarketResearchReports.com
Key Highlights:
TCR-Ts have so far operated in the shadow of CAR-Ts,
but may have the advan...
www.MarketResearchReports.com
Key Highlights: Continues…
The report highlights the value of TCR-T assets in
terms of part...
www.MarketResearchReports.com
Key questions answered:
Which targets are chosen for developmen of TCR-Ts?
How close are n...
www.MarketResearchReports.com
Key questions answered: Continues…
How tough is competition among TCR-T developers?
Should...
www.MarketResearchReports.com
Target audience:
1. Leading Pharmaceutical companies
2. Suppliers
3. Contractors
4. Technolo...
www.MarketResearchReports.com
Target audience: Continues…
12. Business development managers
13. Investors
14. Governments
...
www.MarketResearchReports.com
Report Coverage:
1. Executive Summary
2. Introduction, Overview & Background
3. Technologies...
www.MarketResearchReports.com
Company Coverage: (Partial List)
1. Adaptimmune
2. Adicet Bio
3. Aeon Therapeutics Shanghai
...
www.MarketResearchReports.com
Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, inves...
www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this public...
Upcoming SlideShare
Loading in …5
×

TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals an industry analysis of technologies, stakeholders, deals & trends

39 views

Published on

Market Research Reports, Inc. has announced the addition of “TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals an industry analysis of technologies, stakeholders, deals & trends” research report to their offering. See more at - http://mrr.cm/UD5

Published in: Healthcare
  • Be the first to comment

  • Be the first to like this

TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals an industry analysis of technologies, stakeholders, deals & trends

  1. 1. www.MarketResearchReports.com : an industry analysis of technologies, pipelines, stakeholders & deals an industry analysis of technologies, stakeholders, deals & trends Category : Pharma & Healthcare All logos and Images mentioned on this slide belong to their respective owners.
  2. 2. www.MarketResearchReports.com Introduction to Report  Launch Date: May 20, 2018  Number of Pages: 294  Geography Coverage: Global  Available Format: PDF Price For Single User License: USD 2,500 Price For Site User License: USD 5,000 Price For Global User License: USD 7,500 Delivery Time: Within 24 Hours (During Working Days)
  3. 3. www.MarketResearchReports.com About the Report T-Cell Receptors (TCR) and Chimeric Antigen Receptors (CAR) are the cutting edge of adoptive T-cell therapy. Both receptors deploy T-cells to target the tumor, but CAR T-cells (CAR-T) are limited to binding to cell surface antigens, while TCR T-cells (TCR-T) recognize peptides (derived from intracellular proteins) presented on the cell surface by the major histocompatibility complex (MHC) class I.
  4. 4. www.MarketResearchReports.com Key Highlights: TCR-Ts have so far operated in the shadow of CAR-Ts, but may have the advantage in solid tumors. The first approved CD19-specific CAR-Ts are indicated for hematologic malignancies, but CAR-Ts were less successful against solid tumors. This report „TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals“ published in May 2018 brings you up-to-date regarding key TCR-T players, key TCR-T technologies and product candidates, business models, deals and funding opportunities. The report analyzes the TCR-T pipelines and stakeholders in the field, especially focused and diversified TCR-T companies and their relationship with academia and major pharma/biotech.
  5. 5. www.MarketResearchReports.com Key Highlights: Continues… The report highlights the value of TCR-T assets in terms of partnering economic conditions, acquisition prices and financing rounds. This report has been prepared by use of in-house databases and desktop search to identify and describe company, product, technology and business/financing profiles which then were evaluated and analyzed with a final outlook describing perspectives with challenges and opportunities. Sources of information are provided by scientific and non-scientific references, e.g. press releases, stock exchange disclosures, presentations, annual reports, fact sheets and patent applications (with hyperlinks leading to the source of information).
  6. 6. www.MarketResearchReports.com Key questions answered: Which targets are chosen for developmen of TCR-Ts? How close are neoantigen-specific TCR-Ts to the clinic? Which technologies are used for generation of T-Cell Receptors? Has clinical proof-of-concept been shown for any TCR- T? How does the TCR-T pipeline look like? What manufacturing strategies and solutions have companies chosen? Are next generation TCR-Ts already in development? What are the key technologies for a successful TCR-T? Who are the key players in the TCR-T field?
  7. 7. www.MarketResearchReports.com Key questions answered: Continues… How tough is competition among TCR-T developers? Should companies be focused on TCR-Ts only or be diversified into various adoptive T-cell therapeutics? Which technologies and assets attract licensees? How is the financing situation for TCR-T? What are the key success factors for TCR-Ts?
  8. 8. www.MarketResearchReports.com Target audience: 1. Leading Pharmaceutical companies 2. Suppliers 3. Contractors 4. Technologists 5. R&D staff 6. Consultants 7. Analyst 8. CSO's 9. CEO’s 10.CIO’s 11.COO’s
  9. 9. www.MarketResearchReports.com Target audience: Continues… 12. Business development managers 13. Investors 14. Governments 15. Agencies 16. Industry organisations 17. Banks
  10. 10. www.MarketResearchReports.com Report Coverage: 1. Executive Summary 2. Introduction, Overview & Background 3. Technologies 4. Pipeline 5. Manufacturing 6. Companies 7. Business Development & Financing 8. Outlook & Perspectives 9. References For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  11. 11. www.MarketResearchReports.com Company Coverage: (Partial List) 1. Adaptimmune 2. Adicet Bio 3. Aeon Therapeutics Shanghai 4. AgenTus Therapeutics 5. Alpine Immune Science 6. Atreca 7. Bellicum Pharmaceuticals 8. BioNTech 9. Bluebird bio 10. Cell Medica 11. CRISPR Therapeutics For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  12. 12. www.MarketResearchReports.com Custom Research:  Are you an industry professional, entrepreneur, venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research. For Any Customization Related query Visit IdeaCenter @ http://www.marketresearchreports.com/idea-center For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to- newsletter
  13. 13. www.MarketResearchReports.com How To Buy This Report? Visit following URL to see Table of Content and purchase this publication: http://mrr.cm/UD5 About Market Research Reports, Inc. Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”. Contact : Mr. Sudeep Chakravarty Email : info@marketresearchreports.com Phone: +1-302-703-9904 (USA) +91-8762746600 (India)

×